Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Explore the latest advancements in the medical management of benign prostatic hyperplasia (BPH), where personalized treatment strategies and an expanding pharmacological toolkit are revolutionizing patient care in urology.
Urology March 18th 2024
The New England Journal of Medicine
This pivotal study demonstrates that the combination of enfortumab vedotin and pembrolizumab not only extends progression-free survival but also significantly improves overall survival rates in patients with untreated advanced urothelial carcinoma.
Oncology, Medical March 11th 2024
MDLinx
AABP represents a significant yet under-recognized consequence of obesity, requiring a multidisciplinary treatment strategy that transcends conventional weight loss advice and addresses the intricate psychological and physical needs of affected individuals.
Endocrinology, Diabetes, Metabolism March 6th 2024
UCSF MedConnection
Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.
Oncology, Medical March 4th 2024
Recent studies suggest a potential link between sildenafil and other ED medications and a lower risk of developing dementia, emphasizing the importance of further clinical trials to explore these preliminary observations.
Clinical Pharmacology February 21st 2024
Clinical Advances in Hematology & Oncology
Understanding the complexities of neuroendocrine prostate cancer (NEPC) is crucial for advancing diagnosis and treatment. Insights into lineage plasticity and novel diagnostic tools, including PET imaging and liquid biopsies, are paving the way for more effective management strategies.
Oncology, Medical February 20th 2024